NCT01460693View on ClinicalTrials.gov

Comparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaemia

PHASE3CompletedINTERVENTIONAL
Enrollment

814

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

March 7, 2018

Study Completion Date

March 7, 2018

Conditions
Myeloid Leukemia, Chronic, Chronic Phase
Interventions
DRUG

Imatinib

Oral Imatinib 100mg daily

DRUG

Dasatinib

Oral Dasatinib 100mg daily

Trial Locations (1)

NE7 7DN

Freeman Hospital, Newcastle upon Tyne

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Newcastle-upon-Tyne Hospitals NHS Trust

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

Hammersmith Hospitals NHS Trust

OTHER

lead

Newcastle University

OTHER